1. Home
  2. DLO vs INDV Comparison

DLO vs INDV Comparison

Compare DLO & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DLO

DLocal Limited

HOLD

Current Price

$14.21

Market Cap

4.5B

ML Signal

HOLD

Logo Indivior PLC

INDV

Indivior PLC

HOLD

Current Price

$34.85

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLO
INDV
Founded
2013
N/A
Country
Uruguay
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
4.7B
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
DLO
INDV
Price
$14.21
$34.85
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$17.25
N/A
AVG Volume (30 Days)
1.8M
1.5M
Earning Date
05-14-2026
06-08-2026
Dividend Yield
1.45%
N/A
EPS Growth
N/A
8100.00
EPS
N/A
1.67
Revenue
N/A
$1,239,000,000.00
Revenue This Year
$41.00
N/A
Revenue Next Year
$26.98
N/A
P/E Ratio
$22.27
$21.37
Revenue Growth
N/A
4.29
52 Week Low
$10.64
$22.30
52 Week High
$16.78
$42.81

Technical Indicators

Market Signals
Indicator
DLO
INDV
Relative Strength Index (RSI) 42.17 42.27
Support Level $13.28 $32.06
Resistance Level $14.67 $35.54
Average True Range (ATR) 0.43 0.86
MACD -0.13 0.17
Stochastic Oscillator 2.76 55.79

Price Performance

Historical Comparison
DLO
INDV

About DLO DLocal Limited

DLocal Ltd is focused on making the complex simple, redefining the online payment experience in emerging markets. Through its technology platform, One dLocal, the company enables world-wide enterprise merchants to get paid (pay-in) and to make payments (pay-out) online in a safe and efficient manner. The company earns revenue from fees charged to merchants in connection with payment processing services for cross-border and local payment transactions. The company operates in a single operating segment, which is payment processing. The company's geographical segments include Latin America and Non-Latin America, with a majority of its revenue being generated from Brazil in the Latin America region.

About INDV Indivior PLC

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Share on Social Networks: